DE69821228D1 - Selektive mmp inhibitoren mit verringerten nebenwirkungen - Google Patents

Selektive mmp inhibitoren mit verringerten nebenwirkungen

Info

Publication number
DE69821228D1
DE69821228D1 DE69821228T DE69821228T DE69821228D1 DE 69821228 D1 DE69821228 D1 DE 69821228D1 DE 69821228 T DE69821228 T DE 69821228T DE 69821228 T DE69821228 T DE 69821228T DE 69821228 D1 DE69821228 D1 DE 69821228D1
Authority
DE
Germany
Prior art keywords
reduced side
side effects
mmp inhibitors
mmp
selective mmp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69821228T
Other languages
English (en)
Other versions
DE69821228T2 (de
Inventor
John Bird
Gary Montana
Elizabeth Wills
Douglas Baxter
Alan Owen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9704350.9A external-priority patent/GB9704350D0/en
Priority claimed from GBGB9802622.2A external-priority patent/GB9802622D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Application granted granted Critical
Publication of DE69821228D1 publication Critical patent/DE69821228D1/de
Publication of DE69821228T2 publication Critical patent/DE69821228T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69821228T 1997-03-03 1998-03-03 Selektive mmp inhibitoren mit verringerten nebenwirkungen Expired - Fee Related DE69821228T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9704350.9A GB9704350D0 (en) 1997-03-03 1997-03-03 Compounds and their therapeutic use
GBGB9802622.2A GB9802622D0 (en) 1998-02-06 1998-02-06 Compounds and their therapeutic use
PCT/GB1998/000659 WO1998039024A1 (en) 1997-03-03 1998-03-03 Selective mmp inhibitors having reduced side-effects

Publications (2)

Publication Number Publication Date
DE69821228D1 true DE69821228D1 (de) 2004-02-26
DE69821228T2 DE69821228T2 (de) 2004-10-21

Family

ID=26311105

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69821228T Expired - Fee Related DE69821228T2 (de) 1997-03-03 1998-03-03 Selektive mmp inhibitoren mit verringerten nebenwirkungen

Country Status (9)

Country Link
US (1) US6818622B2 (de)
EP (1) EP0981366B1 (de)
JP (1) JP2001513813A (de)
AT (1) ATE258063T1 (de)
AU (1) AU741903C (de)
CA (1) CA2280134A1 (de)
DE (1) DE69821228T2 (de)
ES (1) ES2212270T3 (de)
WO (1) WO1998039024A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024763A1 (en) * 1998-10-23 2000-05-04 Darwin Discovery Limited Single morphic forms of known peptide metalloproteinase inhibitors
WO2001026671A1 (en) * 1999-10-12 2001-04-19 Smithkline Beecham Corporation Methods of treatment using dual matrix-metalloproteinase-2 and matrix metalloproteinase-9 inhibitors
CN101456860B (zh) * 2007-12-10 2011-02-16 中国科学院上海药物研究所 4-[9-(6-氨基嘌呤基)]-2(s)-羟基丁酸甲酯的制备方法
AU2008350907A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211706D0 (en) * 1992-06-03 1992-07-15 Celltech Ltd Peptidyl derivatives
AU6575394A (en) * 1993-04-27 1994-11-21 Celltech Therapeutics Limited Peptidyl derivatives as metalloproteinase inhibitors
GB9323165D0 (en) * 1993-11-10 1994-01-05 Chiros Ltd Compounds
PL183510B1 (pl) * 1994-10-05 2002-06-28 Darwin Discovery Ltd Związki peptydowe oraz środek farmaceutyczny
AU706064B2 (en) * 1995-05-10 1999-06-10 Darwin Discovery Limited Peptide compounds which inhibit metalloproteinase and TNF liberation, and their therapeutic use
ES2186803T3 (es) * 1995-10-05 2003-05-16 Darwin Discovery Ltd Peptidos tio-sustituidos como inhibidores de metaloproteinasas y de la liberacion de tnf.
GB9523066D0 (en) * 1995-11-10 1996-01-10 Chiroscience Ltd Compounds and their therapeutic use

Also Published As

Publication number Publication date
AU741903B2 (en) 2001-12-13
EP0981366A1 (de) 2000-03-01
EP0981366B1 (de) 2004-01-21
JP2001513813A (ja) 2001-09-04
AU741903C (en) 2002-09-05
CA2280134A1 (en) 1998-09-11
ES2212270T3 (es) 2004-07-16
US20020035065A1 (en) 2002-03-21
ATE258063T1 (de) 2004-02-15
DE69821228T2 (de) 2004-10-21
WO1998039024A1 (en) 1998-09-11
AU6630698A (en) 1998-09-22
US6818622B2 (en) 2004-11-16

Similar Documents

Publication Publication Date Title
MA26812A1 (fr) Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases
TR28718A (tr) Dinamik takilan tipte cocuk bezi.
BG105369A (en) Arylpiperazines and their use as metalloproteinase inhibiting agent (mmp
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
DE69621021D1 (de) Inhibitoren der plättchenaggregation
ATE282600T1 (de) Salpetersäuresalze von antihypertensiven arzneimitteln
YU53899A (sh) Primena inhibitora ciklooksigenaze-2 u prevenciji kardiovaskularnih poremećaja
ATE266000T1 (de) Hydroxamsäure- und carbonsäure-derivate mit mmp und tnf hemmender wirkung
DE69115280D1 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
TR199802106A3 (tr) Sübstitüe edilmis izokinolin-3-karbon asidi amidleri.
DK1032414T3 (da) Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet
DK0859784T3 (da) Thiosubstituerede peptider som inhibitorer af metalloproteinaser og TNF-frigivelse
DE4494827D2 (de) Aktiver Schalldämpfer
DE29809075U1 (de) Dynamischer, displayartiger Schmuckgegenstand
BR9809848A (pt) Composição
IT1302243B1 (it) Sintesi dell'1,1,1,3,3-pentafluoropropano.
ZA978307B (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase.
TR199900505T2 (de)
DE69625230T2 (de) Thrombininhibitoren
DE69821228T2 (de) Selektive mmp inhibitoren mit verringerten nebenwirkungen
DE69800357D1 (de) Feste, nicht zerfliessbare formulierung von natrium valproat
ATE320422T1 (de) Metalloproteinase inhibitoren
ATE28188T1 (de) Antikonvulsive mittel.
ATE57526T1 (de) P-acylaminobenzamide.
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee